Gnubiotics Sciences is a biotechnology company based in Switzerland.
GNUBiotics is developing a compound to reproduce the natural diversity and complexity of unique structures found in breast milk. These structures are beneficial in preventing infections and the onset of diet-induced obesity. It aims at feeding the microbiome. In response to the rising demand for healthier foods they are developing functional and structural mimics of Human Milk Oligosaccharides, (HMOs) for the consumer health market. Their products reproduce the natural diversity and complexity of HMOs and have been shown to be beneficial in preventing the onset of gut infection and protect against the effect of antibiotic use.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 29, 2020 | Debt Financing | Fr787K | 1 | UBS | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
UBS | Yes | Debt Financing |